PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

40 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Waltenberger, M.* et al.: Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): Study protocol for a randomized phase III trial. BMC Cancer 23:709 (2023)
2.
Ebert, K.* et al.: Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF. BMC Cancer 22:254 (2022)
3.
Manuelli, V.* et al.: Invadopodia play a role in prostate cancer progression. BMC Cancer 22:386 (2022)
4.
Voglhuber, T.* ; Eitz, K.A. ; Oechsner, M.* ; Vogel, M.M. & Combs, S.E.: Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival. BMC Cancer 21:780 (2021)
5.
Wenter, V.* et al.: The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study. BMC Cancer 21:139 (2021)
6.
Aftahy, A.K.* et al.: Intraventricular neuroepithelial tumors: Surgical outcome, technical considerations and review of literature. BMC Cancer 20:1060 (2020)
7.
Devecka, M.* et al.: Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: Risk-benefit-profile and development of a prognostic score for decision making in the palliative setting. BMC Cancer 20:501 (2020)
8.
Ebert, K.* et al.: Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7). BMC Cancer 20:1127 (2020)
9.
Ebert, K.* et al.: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines. BMC Cancer 20:1039 (2020)
10.
Kessel, K.A. et al.: Stereotactic body radiotherapy (SBRT) in patients with lung metastases-prognostic factors and long-term survival using patient self-reported outcome (PRO). BMC Cancer 20:442 (2020)
11.
Oehus, A.K.* et al.: Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy. BMC Cancer 20:362 (2020)
12.
Schmid, S.C.* et al.: Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT). BMC Cancer 20:8 (2020)
13.
Voglhuber, T.* et al.: Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases. BMC Cancer 20:536 (2020)
14.
Borm, K.J.* et al.: Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients. BMC Cancer 19:907 (2019)
15.
Dapper, H.* et al.: Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines. BMC Cancer 19:742 (2019)
16.
Borm, K.J.* et al.: Moving targets in 4D-CTs versus MIP and AIP: Comparison of patients data to phantom data. BMC Cancer 18:760 (2018)
17.
Straube, C.* et al.: Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17-ARO 2016/3-DKTK ROG trial). BMC Cancer 18:15 (2018)
18.
Straube, C.* et al.: A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802-results from a multi-center survey. BMC Cancer 18:907 (2018)
19.
Duma, M.N. ; Münch, S.* ; Oechsner, M.* & Combs, S.E.: Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries. BMC Cancer 17:563 (2017)
20.
Habl, G.* et al.: Oligometastases from prostate cancer: Local treatment with stereotactic body radiotherapy (SBRT). BMC Cancer 17:361 (2017)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮